See also this year's filing and all EDGAR filings for this company.
PDF Report 0001048477_2011_Biomarin_Pharmaceutical_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001048477, Biomarin Pharmaceutical INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 504,260,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 157,012,000 |
| 2 | PropertyPlantAndEquipmentNet | 221,866,000 |
| 3 | remainder_Assets | 379,485,000 |
| 4 | LiabilitiesCurrent | 83,844,000 |
| 5 | LiabilitiesNoncurrent | 84,001,000 |
| 6 | remainder_Liabilities | 377,521,000 |
| 7 | CostOfGoodsAndServicesSold | 70,285,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 151,723,000 |
| 9 | ResearchAndDevelopmentExpense | 147,309,000 |
| 10 | remainder_Expenses | -196,846,000 |
| 11 | remainder_Revenues | 376,267,000 |
| 12 | remainder_NetIncome | 2,023,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,262,623,000 |
| 1 | Liabilities | 545,366,000 |
| 2 | Expenses | 172,471,000 |
| 3 | Revenues | 376,267,000 |
| 4 | StockholdersEquity | 717,257,000 |
| 5 | NetIncome | 205,819,000 |
| 6 | ComprehensiveNetIncome | 205,819,000 |
| 7 | BaseVar | 1,179,375,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.96 |
| 9 | EconomicCapitalRatio | 3.00 |
Edgar->Model Mapping
Feature Distribution
